Has Jamil Shah, MD received payments from drug or device companies?

Yes. Drug and device makers reported $55,416 in general payments to Jamil Shah, MD across 556 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jamil Shah, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jamil Shah, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jamil Shah, MD

Gastroenterology · Newark, NJNPI 1235535436

Payments from drug & device makers

$55,416in general payments, 2019–2025

Across 556 payments — averaging $99.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$9K
Boston Scientific$5K
Madrigal Pharmaceuticals$4K
Gilead$4K
Boehringer Ingelheim$4K
Wilson Cook Medical Incorporated$4K
plus $26K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	100	$9,254
Boston Scientific	36	$4,735
Madrigal Pharmaceuticals	33	$4,012
Gilead	48	$3,775
Boehringer Ingelheim	30	$3,616
Wilson Cook Medical Incorporated	16	$3,589
Olympus Corporation Of The Americas	39	$3,119
Johnson & Johnson(2 entities)	36	$3,015
Medtronic	21	$2,296
E.r. Squibb & Sons, L.L.C.	16	$1,976
Novo Nordisk	13	$1,592
Cook Medical LLC	21	$1,582
Viiv Healthcare Company	10	$1,205
Lilly USA, LLC	19	$1,082
Genentech USA, Inc.	5	$628
Ovesco Endoscopy USA, Inc.	1	$568
Takeda Pharmaceuticals U.S.A., Inc.	10	$554
Phathom Pharmaceuticals, Inc.	4	$523
AstraZeneca(2 entities)	4	$494
Celltrion USA Inc.	6	$442
Micro-tech Endoscopy USA, Inc.	5	$406
Amgen	5	$394
Merck	4	$379
Bayer	4	$347
GSK	5	$337
Pfizer	9	$337
Daiichi Sankyo Inc.	4	$305
Exelixis Inc.	2	$255
Incyte Corporation	2	$250
Sanofi-aventis U.S. LLC	2	$250
Eisai Inc.	2	$250
Dova Pharmaceuticals	2	$245
EMD Serono, Inc.	2	$242
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$239
Astellas Pharma US Inc	2	$237
Merit Medical Systems Inc	1	$199
Ardelyx, Inc.	5	$191
Fujifilm Healthcare Americas Corporation	2	$176
Dynavax Technologies Corporation	2	$156
Heron Therapeutics, Inc.	1	$141
Janssen Scientific Affairs, LLC	1	$138
Ferring Pharmaceuticals Inc.	1	$129
Chiesi USA, Inc.	1	$128
CSL Behring	1	$125
Aimmune Therapeutics, Inc.	1	$125
Mylan Specialty L.p.	1	$125
Intercept Pharmaceuticals, Inc.	1	$125
Alnylam Pharmaceuticals Inc.	1	$125
Tesaro, Inc.	1	$125
Insmed, Inc.	1	$121
Sanofi	1	$118
Bristol Myers Squibb	1	$118
Redhill Biopharma Inc.	1	$112
Seagen Inc.	1	$101
AVEO Pharmaceuticals, Inc.	1	$94
W. L. Gore & Associates, Inc.	2	$50
Nestle Healthcare Nutrition Inc.	2	$47
Braintree Laboratories, Inc.	1	$26
ERBE USA Inc	1	$25
Exact Sciences	1	$24

How this compares

$55,416 in reported general payments places this provider in the 90th percentile of 701 gastroenterology providers in New Jersey.

See all gastroenterology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$19,411

Medicare patients

Services billed

151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Newark

Zamir BrelviNewark$408K
Kiran RaoSparta$1.3M
Adekunle AdeotiIrvington$1.2M
Carl WallachMorristown$766K
Vinod RustgiNew Brunswick$697K
Arvind TrindadeNew Brunswick$652K
Barry KaufmanEgg Harbor Township$595K
Promila BanerjeeStratford$522K
Neil NagariaToms River$442K
Adam ElfantMount Laurel$385K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →